Very low energy ketogenic therapy
3 papers5 findings
- 1 lab in 1 country
- Human trial2
Outcomes
5Systolic blood pressure
no changein humans1
1 study
Systolic blood pressure
no changein humans1
Very low energy ketogenic therapy has no effect on systolic blood pressure in humans.
“systolic blood pressure did not show a significant change”
Human trial45 days
ENDO 2025 abstract22 Oct 2025
Triglyceride
downin humans1
1 study
Triglyceride
downin humans1
Very low energy ketogenic therapy decreases triglyceride in humans.
“triglyceride (TG) levels showed a marked reduction in the MetS group”
Human trialin metabolic syndrome patients45 days
ENDO 2025 abstract22 Oct 2025
Diastolic blood pressure
downin humans1
1 study
Diastolic blood pressure
downin humans1
Very low energy ketogenic therapy decreases diastolic blood pressure in humans (70.0 mmHg vs. 80.0 mmHg, p = 0.016).
“A notable improvement in diastolic blood pressure was observed (70.0 mmHg vs. 80.0 mmHg, p = 0.016)”
Human trialin metabolic syndrome patients45 days
ENDO 2025 abstract22 Oct 2025
Body weight
downin humans1
1 study
Body weight
downin humans1
Very low energy ketogenic therapy decreases body weight in humans (88.4 ± 11.1 kg vs. 97.6 ± 12.1 kg, p = 0.011).
“Body weight (BW) significantly decreased from baseline to the end of the VLEKT phase (88.4 ± 11.1 kg vs. 97.6 ± 12.1 kg, p = 0.011)”
Human trialin metabolic syndrome patients45 days
ENDO 2025 abstract22 Oct 2025
Obesity
downin humans1
1 study
Obesity
downin humans1
Very low energy ketogenic therapy decreases obesity in humans.
“VLEKT is an innovative approach to obesity treatment, offering a target-oriented and highly effective strategy for people fighting against overweight and its associated medical complications.”
Review
Current obesity reports3 Apr 2025